NEW YORK, NY / ACCESS Newswire / March 14, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers ...

The drugmaker Merck announced it has opened a $1 billion vaccine manufacturing facility in north Durham, a ...

At its sprawling complex in Durham, N.C., Merck has opened a new $1 billion, 225,000-square-foot manufacturing plant slated ...

A federal judge ruled in favor of Merck in litigation accusing it of concealing the risks of Gardasil, a vaccine to prevent ...

Investors with a lot of money to spend have taken a bullish stance on Merck & Co MRK. And retail traders should know. We noticed this today when the trades showed up on publicly available options ...

Investors with a lot of money to spend have taken a bullish stance on Merck & Co MRK. And retail traders should know. We noticed this today when the trades showed up on publicly available options ...

In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other best cheap dividend stocks to buy right now. Value investing has remained a favored approach ...

Both Merck & Co. and Halozyme are holding their ground in a freshly unveiled patent dispute surrounding the New Jersey pharma’s under-the-skin version of its blockbuster cancer drug Keytruda.

Merck said on Tuesday it has opened a $1-billion facility at its North Carolina site, the latest drugmaker to boost its U.S.

U.S. District Judge Kenneth Bell ruled in Merck’s (MRK) favor in a safety lawsuit over the company’s Gardasil vaccine, allowing the pharma giant to sidestep over 200 complaints alleging the ...

March 11 (Reuters) - A federal judge ruled in favor of Merck (MRK.N), opens new tab in litigation accusing it of concealing the risks of Gardasil, a vaccine to prevent cervical and other cancers ...